An oddity of that gp2 SABCS poster is that it isn’t authored by the PI of the Ph 2 study. That would be Dr Mittendorf from MD Anderson. Instead it’s authored by people associated with the biotech. And I see it says all of the subjects in that subset received Herceptin. So looking at 50 pts that got Herceptin shouldn’t have caused such a market reaction. That’s weird but good for anyone that got lucky cashing in.